DJ Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ slid 2.17% to $486.03 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.04% to 6,881.62 and the Dow Jones Industrial Average falling 0.15% to 48,904.78.
Vertex Pharmaceuticals Inc. closed 6.48% short of its 52-week high of $519.68, which the company achieved on March 14th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ rose 0.94% to $234.26, Krystal Biotech Inc. (KRYS) fell 6.11% to $258.81, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 1.46% to $8.35.
Trading volume (1.0 M) remained 432,663 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 2, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 02, 2026 16:37 ET (21:37 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.